日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial

使用 iGlarLixi 进行胰岛素治疗降阶:一项 4 期、开放标签、平行组随机对照试验

Novodvorský, Peter; Thieme, Lenka; Laňková, Ivana; Franková, Štěpánka; Veselá, Alica; Záhumenský, Emil; Edelsberger, Tomáš; Löblová, Marie; Žižka, Ondřej; Vytasil, Miroslav; Lauand, Felipe; Bonnemaire, Mireille; Hrubý, Filip; Mráz, Miloš; Haluzík, Martin

The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol

IDEAL(胰岛素治疗降阶治疗与伊格瑞洛联合用药)随机对照试验研究设计及方案

Novodvorský, Peter; Thieme, Lenka; Laňková, Ivana; Mráz, Miloš; Taybani, Zoltán J; Bótyik, Balázs; Stella, Péter; Vytasil, Miroslav; Lauand, Felipe; Bonnemaire, Mireille; Haluzík, Martin